ROSA MARÍA
AYALA DÍAZ
Profesora asociada de Ciencias de la Salud
University of Paris-Sorbonne
París, FranciaPublikationen in Zusammenarbeit mit Forschern von University of Paris-Sorbonne (1)
2023
-
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
The Lancet, Vol. 401, Núm. 10373, pp. 269-280